King Bio Recalls Dr. King's SafeCare Rx Overly-Sensitive Due to Microbial Contamination
King Bio Inc. is recalling 24 bottles of Dr. King's SafeCare Rx Overly-Sensitive (Lot 112117H) due to microbial contamination. The product was distributed in the U.S., Canada, and Australia.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA has classified this recall as Class I, which meets the rubric criteria for a Critical severity score (5).
Plain-English summary
King Bio Inc. is recalling 24 bottles of Dr. King's SafeCare Rx Overly-Sensitive, 2 fl. oz. (59 mL), due to microbial contamination. The affected product is identified by Lot 112117H and an expiration date of 11/19. The product carries the NDC 57955-2071-2 and UPC 357955207023.
The recall covers distribution in the U.S.A. Nationwide, Canada, and Australia. The FDA has classified this recall as Class I, indicating a reasonable probability that use of or exposure to the violative product may cause serious adverse health consequences or death.
Consumers who have purchased this specific lot should stop using the product and contact King Bio Inc. for further instructions or a refund.
The recalled product
- Product
- Dr. King's SafeCare Rx Overly-Sensitive, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955207023, NDC 57955-2071-2
- Manufacturer
- King Bio Inc.
- Category
- Drug — Topical
- Hazard
- Affected units
- 24
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 112117H Exp. 11/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereMuscle Rage King Test Capsules Recalled for Undeclared Milk
FDA (Food) · 2022-01-19
- ModeratePfizer Recalls Oxecta Tablets Due to Failed Impurity Specifications
FDA (Drugs) · 2015-03-11
- LowAdvanced Pharma Recalls Oxytocin Injectable Solution Due to Superpotent Drug Concerns
FDA (Drugs) · 2019-02-27
- HighFDA Recalls HyperLyte CR Injection for Lack of Sterility Assurance
FDA (Drugs) · 2023-05-31
- SeverePharmedium Recalls Sub-Potent Fentanyl and Ropivacaine Injection Syringes
FDA (Drugs) · 2018-12-26
- SevereRXQ Compounding Recalls Avastin Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-14